Compound ID | 838
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive |
| Details of activity: | Use against Chlamydia |
| Institute where first reported: | Versicor (Merged with Biosearch Italia) |
| Year first mentioned: | 2002 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Did not show superiority over existing marketed antibiotics- (LS) |
| External links: | |
| Citation: |